PURPOSE: Fuchs corneal dystrophy (FCD) is an autosomal dominant disease of the corneal endothelium with variable penetrance and expressivity. Recently, rs613872, an intronic variation of TCF4 associated with late-onset FCD, was reported. The present study was undertaken to examine this association in our cohort of FCD patients, to assess the significance of this finding, and to investigate the candidacy of TCF4 in the context of the mapped FCD2 locus. METHODS: The authors recruited 170 patients with late-onset FCD and 180 age-matched controls. Blood samples were collected, and genomic DNA was extracted. A panel of nine SNPs spanning the entire TCF4 locus was genotyped both on this cohort and on three previously reported FCD2-linked families. The association of an individual SNP with late-onset FCD was evaluated with the Fisher exact test, and the coding exons and exon-intron boundaries of TCF4 were sequenced in 96 affected persons. RESULTS: The risk allele G of rs613872 is associated significantly with late-onset FCD (odds ratio, 4.2; P = 4.28 x 10⁻¹⁵) and was present in male and female affected persons without any sex bias, replicating recent findings, though the authors found no apparent correlation with the severity of the disease phenotype. Moreover, the risk allele did not cosegregate with the disease phenotype in any of the three FCD2-linked families. The authors did not identify any pathogenic variants in the coding region of TCF4. CONCLUSIONS: The authors report the first independent replication of rs613872 conferring risk of late-onset FCD. Their data suggest that this risk factor is likely independent of the FCD2 locus, whose causality remains unknown.
PURPOSE:Fuchs corneal dystrophy (FCD) is an autosomal dominant disease of the corneal endothelium with variable penetrance and expressivity. Recently, rs613872, an intronic variation of TCF4 associated with late-onset FCD, was reported. The present study was undertaken to examine this association in our cohort of FCDpatients, to assess the significance of this finding, and to investigate the candidacy of TCF4 in the context of the mapped FCD2 locus. METHODS: The authors recruited 170 patients with late-onset FCD and 180 age-matched controls. Blood samples were collected, and genomic DNA was extracted. A panel of nine SNPs spanning the entire TCF4 locus was genotyped both on this cohort and on three previously reported FCD2-linked families. The association of an individual SNP with late-onset FCD was evaluated with the Fisher exact test, and the coding exons and exon-intron boundaries of TCF4 were sequenced in 96 affected persons. RESULTS: The risk allele G of rs613872 is associated significantly with late-onset FCD (odds ratio, 4.2; P = 4.28 x 10⁻¹⁵) and was present in male and female affected persons without any sex bias, replicating recent findings, though the authors found no apparent correlation with the severity of the disease phenotype. Moreover, the risk allele did not cosegregate with the disease phenotype in any of the three FCD2-linked families. The authors did not identify any pathogenic variants in the coding region of TCF4. CONCLUSIONS: The authors report the first independent replication of rs613872 conferring risk of late-onset FCD. Their data suggest that this risk factor is likely independent of the FCD2 locus, whose causality remains unknown.
Authors: John D Gottsch; Cheng Zhang; Olof H Sundin; W Robert Bell; Walter J Stark; W Richard Green Journal: Invest Ophthalmol Vis Sci Date: 2005-12 Impact factor: 4.799
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar Journal: Cell Date: 1989-08-11 Impact factor: 41.582
Authors: John D Gottsch; Olof H Sundin; Sammy H Liu; Albert S Jun; Karl W Broman; Walter J Stark; Elizabeth C L Vito; Amol K Narang; John M Thompson; Malcolm Magovern Journal: Invest Ophthalmol Vis Sci Date: 2005-06 Impact factor: 4.799
Authors: S Amer Riazuddin; David S Parker; Elyse J McGlumphy; Edwin C Oh; Benjamin W Iliff; Thore Schmedt; Ula Jurkunas; Robert Schleif; Nicholas Katsanis; John D Gottsch Journal: Am J Hum Genet Date: 2012-02-16 Impact factor: 11.025
Authors: Vivek S Yellore; Sylvia A Rayner; Catherine K Nguyen; Rajendra K Gangalum; Zhe Jing; Suraj P Bhat; Anthony J Aldave Journal: Invest Ophthalmol Vis Sci Date: 2012-01-25 Impact factor: 4.799
Authors: Chao Xing; Xin Gong; Imran Hussain; Chiea-Chuen Khor; Donald T H Tan; Tin Aung; Jodhbir S Mehta; Eranga N Vithana; V Vinod Mootha Journal: Invest Ophthalmol Vis Sci Date: 2014-10-08 Impact factor: 4.799
Authors: Eric D Wieben; Ross A Aleff; Bruce W Eckloff; Elizabeth J Atkinson; Saurabh Baheti; Sumit Middha; William L Brown; Sanjay V Patel; Jean-Pierre A Kocher; Keith H Baratz Journal: Invest Ophthalmol Vis Sci Date: 2014-08-28 Impact factor: 4.799